Invizyne's nasdaq ipo marks new era of biomanufacturing

Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations associated with traditional cell-based synthetic biology
MDBH Ratings Summary
MDBH Quant Ranking